[go: up one dir, main page]

AU2019335515A1 - Systems and methods for microbiome analysis - Google Patents

Systems and methods for microbiome analysis Download PDF

Info

Publication number
AU2019335515A1
AU2019335515A1 AU2019335515A AU2019335515A AU2019335515A1 AU 2019335515 A1 AU2019335515 A1 AU 2019335515A1 AU 2019335515 A AU2019335515 A AU 2019335515A AU 2019335515 A AU2019335515 A AU 2019335515A AU 2019335515 A1 AU2019335515 A1 AU 2019335515A1
Authority
AU
Australia
Prior art keywords
subject
sample
activity
methods
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2019335515A
Other languages
English (en)
Inventor
Guruduth S. Banavar
Helen MESSIER
Ally PERLINA
Momchilo VUYISICH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viome Life Sciences Inc
Original Assignee
Viome Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viome Life Sciences Inc filed Critical Viome Life Sciences Inc
Publication of AU2019335515A1 publication Critical patent/AU2019335515A1/en
Assigned to Viome Life Sciences, Inc. reassignment Viome Life Sciences, Inc. Amend patent request/document other than specification (104) Assignors: Viome, Inc.
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Data Mining & Analysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Databases & Information Systems (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2019335515A 2018-09-06 2019-09-06 Systems and methods for microbiome analysis Pending AU2019335515A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862728035P 2018-09-06 2018-09-06
US62/728,035 2018-09-06
PCT/US2019/050102 WO2020051559A1 (en) 2018-09-06 2019-09-06 Systems and methods for microbiome analysis

Publications (1)

Publication Number Publication Date
AU2019335515A1 true AU2019335515A1 (en) 2021-04-29

Family

ID=69723304

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019335515A Pending AU2019335515A1 (en) 2018-09-06 2019-09-06 Systems and methods for microbiome analysis

Country Status (5)

Country Link
US (1) US20210332418A1 (de)
EP (1) EP3847273A4 (de)
AU (1) AU2019335515A1 (de)
CA (1) CA3112004A1 (de)
WO (1) WO2020051559A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210398449A1 (en) 2018-10-08 2021-12-23 Naveen Jain Methods for and compositions for determining food item recommendations
WO2020168015A1 (en) 2019-02-12 2020-08-20 Viome, Inc. Personalizing food recommendations to reduce glycemic response
WO2021195604A2 (en) * 2020-03-27 2021-09-30 Viome, Inc. Diagnostic for oral cancer
CN112712856A (zh) * 2020-12-25 2021-04-27 北京群峰纳源健康科技有限公司 一种基于肠道菌群分析膳食结构的方法
WO2022266266A1 (en) 2021-06-15 2022-12-22 Viome Life Sciences, Inc. Methods and compositions for evaluating and treating blood glucose dysregulation
EP4303325A1 (de) 2022-07-05 2024-01-10 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Verfahren zum bestimmen von bakteriellen metaboliten zur individualisierten ernährungseinstellung
WO2025096651A1 (en) * 2023-11-01 2025-05-08 Cipher Genetics, Inc. Systems and methods for nutrigenomics and nutrigenetic analysis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150057574A1 (en) * 2013-08-23 2015-02-26 Elwha Llc Selecting and Delivering Treatment Agents based on a Microbe Profile
US10325685B2 (en) * 2014-10-21 2019-06-18 uBiome, Inc. Method and system for characterizing diet-related conditions
EP3386592A4 (de) * 2015-12-09 2019-05-22 Ubiome, Inc. Verfahren und system zur charakterisierung mit clostridium difficile assoziierten erkrankungen
WO2018036503A1 (en) * 2016-08-25 2018-03-01 The Chinese University Of Hong Kong Fecal bacterial markers for colorectal cancer
US20240127925A1 (en) * 2021-02-03 2024-04-18 Tata Consultancy Services Limited Method and system for designing personalized therapeutics and diet based on functions of microbiome

Also Published As

Publication number Publication date
EP3847273A4 (de) 2022-06-08
US20210332418A1 (en) 2021-10-28
WO2020051559A1 (en) 2020-03-12
EP3847273A1 (de) 2021-07-14
CA3112004A1 (en) 2020-03-12

Similar Documents

Publication Publication Date Title
US20210332418A1 (en) Systems and methods for microbiome analysis
Lim et al. Stability of gut enterotypes in Korean monozygotic twins and their association with biomarkers and diet
Tang et al. Screening of microbes associated with swine growth and fat deposition traits across the intestinal tract
Solomon et al. Protozoa populations are ecosystem engineers that shape prokaryotic community structure and function of the rumen microbial ecosystem
Hou et al. Differential fecal microbiota are retained in broiler chicken lines divergently selected for fatness traits
Huber et al. Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
Fart et al. Differences in gut microbiome composition between senior orienteering athletes and community-dwelling older adults
Afolayan et al. Impact of a nomadic pastoral lifestyle on the gut microbiome in the Fulani living in Nigeria
Borrello et al. Dietary intake mediates ethnic differences in gut microbial composition
Elokil et al. Investigation of the impacts of antibiotic exposure on the diversity of the gut microbiota in chicks
Fu et al. Characterization of the gut microbiome in epidemiologic studies: the multiethnic cohort experience
Carvalho et al. Antimicrobial resistance genes and diversity of clones among faecal ESBL-producing Escherichia coli isolated from healthy and sick dogs living in Portugal
Schreurs et al. How the gut microbiome links to menopause and obesity, with possible implications for endometrial cancer development
Ansari et al. Lactobacillus probiotics improve vaginal dysbiosis in asymptomatic women
US20220344003A1 (en) Biomarkers for Age
McCann et al. Enterolignan production in a flaxseed intervention study in postmenopausal US women of African ancestry and European ancestry
Andreu-Sánchez et al. Global genetic diversity of human gut microbiome species is related to geographic location and host health
Boolani et al. Trait energy and fatigue may be connected to gut bacteria among young physically active adults: An exploratory study
Peng et al. The gut microbiota profile in children with Prader–Willi syndrome
Lopez Leyva et al. Human milk microbiome is shaped by breastfeeding practices
He et al. Treatment with mixed probiotics induced, enhanced and diversified modulation of the gut microbiome of healthy rats
Pi et al. Effects of different feeding methods on the structure, metabolism, and gas production of infant and toddler intestinal flora and their mechanisms
Zhou et al. Rumen and fecal microbiota characteristics of Qinchuan cattle with divergent residual feed intake
US20240306691A1 (en) Personalized Nutritional Supplements and Methods of Making
Wang et al. The multi-omics analysis revealed a metabolic regulatory system of cecum in rabbit with diarrhea

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: VIOME LIFE SCIENCES, INC.

Free format text: FORMER NAME(S): VIOME, INC.